Topic: Policy

  • R&D Costs Do Not Explain Elevated U.S. Drug Prices

  • The U.S. Government Should Buy Gilead for $156Bn to Save Money on Hep C

  • Hospital Outpatient versus Doctor Office Cost for Physician Administered Cancer Drugs

    Hospital Outpatient versus Doctor Office Cost for Physician Administered Cancer Drugs

  • Copay Assistance for Expensive Drugs: A Helping Hand That Raises Costs

  • Part B Payment for Medicare Drugs

    Part B Payment for Medicare Drugs

  • Overspending Driven by Oversized Single Dose Vials of Cancer Drugs

    Overspending Driven by Oversized Single Dose Vials of Cancer Drugs

  • The 340B Program: Hospitals Profit by Reaching Affluent Communities

  • Unpronounceable Drugs, Incomprehensible Prices

  • Reforming the Payment System for Medical Oncology

  • Cost Consequences of the 340B Drug Discount Program